Close

Biogen (BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg

Go back to Biogen (BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg

FDA: No Change in Role of Neuroscience Director Billy Dunn - Bloomberg, Citing FDA Statement

March 15, 2021 5:40 PM EDT

FDA: No Change in Role of Neuroscience Director Billy Dunn - Bloomberg, Citing FDA Statement

... More

Biogen (BIIB) Comments to Truist Analyst About Billy Dunn

March 15, 2021 5:17 PM EDT

Truist Research analyst Robyn Karnauskas asked Biogen (NASDAQ: BIIB) two questions related to Billy Dunn and received a response from mangaement.

1) is Billy Dunn still at FDA?

As far as mgmt knows, Billy Dunn is still listed as Director of... More

Biogen (BIIB) sinks 5% intra-day

March 15, 2021 1:29 PM EDT

Biogen (NASDAQ: BIIB) sinks 5% intra-day

... More